At close: December 13 at 1:30:32 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
884,107.00
828,501.00
767,753.00
737,892.00
485,598.00
Cost of Revenue
611,060.00
588,962.00
590,289.00
574,347.00
402,441.00
Gross Profit
273,047.00
239,539.00
177,464.00
163,545.00
83,157.00
Operating Expense
167,680.00
149,293.00
138,202.00
128,105.00
126,923.00
Operating Income
105,367.00
90,246.00
39,262.00
35,440.00
-43,766.00
Net Non Operating Interest Income Expense
369.00
-297.00
-5,239.00
-6,521.00
-4,620.00
Pretax Income
118,570.00
106,470.00
62,807.00
19,617.00
-63,693.00
Tax Provision
19,898.00
21,887.00
15,779.00
-938.00
-1,481.00
Net Income Common Stockholders
99,687.00
85,710.00
48,498.00
22,592.00
-59,987.00
Diluted NI Available to Com Stockholders
99,687.00
85,710.00
48,498.00
22,592.00
-59,987.00
Basic EPS
1.95
1.68
1.00
0.45
-1.18
Diluted EPS
1.93
1.67
1.00
0.45
-1.18
Basic Average Shares
51,059.51
50,932.00
50,685.00
50,684.55
50,684.55
Diluted Average Shares
51,674.04
51,319.00
50,929.00
50,763.30
50,684.55
Total Expenses
778,740.00
738,255.00
728,491.00
702,452.00
529,364.00
Net Income from Continuing & Discontinued Operation
99,687.00
85,710.00
48,498.00
22,592.00
-59,987.00
Normalized Income
100,522.51
85,941.97
48,336.27
22,362.40
-61,484.35
Interest Income
9,848.00
10,699.00
3,948.00
1,294.00
3,848.00
Interest Expense
9,479.00
10,996.00
9,187.00
7,815.00
8,468.00
Net Interest Income
369.00
-297.00
-5,239.00
-6,521.00
-4,620.00
EBIT
128,049.00
117,466.00
71,994.00
27,432.00
-55,225.00
EBITDA
164,084.00
152,181.00
105,466.00
64,414.00
-17,475.00
Reconciled Cost of Revenue
611,060.00
588,962.00
590,289.00
574,347.00
402,441.00
Reconciled Depreciation
36,035.00
34,715.00
33,472.00
36,982.00
37,750.00
Net Income from Continuing Operation Net Minority Interest
99,687.00
85,710.00
48,498.00
22,592.00
-59,987.00
Total Unusual Items Excluding Goodwill
-1,004.00
-292.00
216.00
287.00
1,533.00
Total Unusual Items
-1,004.00
-292.00
216.00
287.00
1,533.00
Normalized EBITDA
165,088.00
152,473.00
105,250.00
64,127.00
-19,008.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-168.49
-60.03
54.27
57.40
35.65
12/31/2020 - 6/20/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4183.TWO EPS Bio Technology Corp.
22.60
-1.53%
4188.TWO AmCad BioMed Corporation
21.70
+0.70%
4735.TWO AViTA Corporation
39.55
-2.83%
4198.TWO S&S Healthcare Holding Ltd.
30.70
-0.65%
4745.TWO Cowealth Medical Holding Co., Ltd.
20.30
-1.22%
6649.TWO Taiwan Biomaterial Co., Ltd.
35.45
-1.25%
6767.TWO Wiltrom Co., Ltd.
32.75
+0.46%
4138.TWO Dynamic Medical Technologies Inc.
91.20
-0.87%
4121.TWO Rossmax International Ltd.
16.10
-2.42%
4106.TW Wellell Inc.
24.35
0.00%